tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Edesa Biotech Inc

EDSA
Add to Watchlist
5.110USD
-0.140-2.67%
Close 07-31 16:00（ET）Quotes delayed by 15 min
49.23MMarket Cap
LossP/E TTM

Edesa Biotech Inc

5.110
-0.140-2.67%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

EDSA Financials

See Edesa Biotech Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Edesa Biotech Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-0.49/-0.26
Revenue / Forecast
--/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.27
34.40%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-64.76%-0.49
41.68%-0.28
-6.63%-0.32
51.89%-0.25
48.58%-0.30
10.47%-0.48
47.87%-0.30
23.55%-0.52
28.74%-0.58
39.25%-0.54
---0.57
---0.68
---0.82
---0.89
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
Net Profit
-165.23%-4.22M
-38.98%-2.25M
-131.63%-2.23M
-4.87%-1.75M
14.55%-1.59M
3.65%-1.62M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
28.11%-1.68M
38.86%-1.72M
65.70%-1.98M
48.91%-2.33M
46.68%-2.33M
23.66%-2.81M
-21.59%-5.79M
-102.18%-4.57M
-66.01%-4.38M
-82.98%-3.69M
-169.54%-4.76M
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
----
----
----
----
----
----
Income Statement
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
Operating profit
-162.19%-4.30M
-23.32%-2.34M
-145.94%-2.47M
1.49%-1.90M
26.19%-1.64M
-2.22%-1.90M
57.61%-1.00M
6.38%-1.93M
7.89%-2.22M
21.90%-1.86M
16.45%-2.37M
64.39%-2.06M
47.31%-2.41M
53.92%-2.38M
48.29%-2.84M
4.53%-5.80M
51.89%-4.58M
-97.48%-5.16M
-172.80%-5.48M
-243.39%-6.07M
Net Profit
-165.23%-4.22M
-38.98%-2.25M
-131.63%-2.23M
-4.87%-1.75M
14.55%-1.59M
3.65%-1.62M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
28.11%-1.68M
38.86%-1.72M
65.70%-1.98M
48.91%-2.33M
46.68%-2.33M
23.66%-2.81M
-21.59%-5.79M
-102.18%-4.57M
-66.01%-4.38M
-82.98%-3.69M
-169.54%-4.76M
Balance Sheet
Current assets
-27.59%10.42M
513.80%12.72M
587.08%11.51M
318.86%12.76M
239.15%14.39M
-61.75%2.07M
-73.97%1.68M
-55.94%3.05M
-47.82%4.24M
-40.39%5.42M
-29.20%6.44M
-54.45%6.91M
-54.84%8.13M
-8.14%9.09M
-24.80%9.09M
5.90%15.18M
-15.96%18.00M
29.01%9.89M
49.19%12.09M
130.43%14.33M
Total current liabilities
139.20%2.19M
-60.21%756.16K
-41.15%1.08M
-71.50%672.67K
-57.47%914.70K
-4.36%1.90M
0.60%1.83M
54.39%2.36M
37.45%2.15M
55.18%1.99M
-14.90%1.82M
-72.97%1.53M
-53.08%1.56M
-26.70%1.28M
46.76%2.14M
475.24%5.66M
-27.81%3.34M
92.74%1.75M
-4.65%1.46M
0.04%983.47K
Total assets
-24.73%12.38M
253.26%14.71M
254.76%13.53M
183.20%14.80M
154.12%16.45M
-46.83%4.16M
-57.10%3.81M
-44.50%5.23M
-39.34%6.48M
-32.92%7.83M
-23.20%8.89M
-46.30%9.42M
-47.70%10.67M
-5.42%11.67M
-20.63%11.58M
3.93%17.54M
-14.97%20.41M
19.95%12.34M
35.52%14.58M
89.15%16.88M
Total liabilities
139.20%2.19M
-60.21%756.16K
-41.15%1.08M
-71.50%672.67K
-57.47%914.70K
-4.36%1.90M
-0.48%1.83M
50.45%2.36M
28.51%2.15M
41.79%1.99M
-15.69%1.84M
-72.49%1.57M
-50.53%1.67M
-21.89%1.40M
43.11%2.18M
431.29%5.70M
-28.46%3.38M
73.62%1.79M
-7.73%1.53M
-4.36%1.07M
Total equity
-34.38%10.20M
516.37%13.95M
528.52%12.45M
392.91%14.13M
259.35%15.54M
-61.27%2.26M
-71.89%1.98M
-63.48%2.87M
-51.95%4.32M
-43.11%5.84M
-24.94%7.05M
-33.68%7.85M
-47.14%9.00M
-2.61%10.27M
-28.08%9.39M
-25.10%11.84M
-11.67%17.02M
13.95%10.55M
43.37%13.06M
102.61%15.80M
Cash Flow Statement
Net operating income
15.39%-2.02M
-37.58%-2.09M
-77.97%-1.72M
-98.58%-1.70M
-43.56%-2.38M
-7.87%-1.52M
34.13%-967.04K
52.56%-856.48K
-5.60%-1.66M
21.47%-1.41M
73.92%-1.47M
40.36%-1.81M
-277.33%-1.57M
44.16%-1.79M
-1483.98%-5.63M
2.97%-3.03M
94.20%-416.65K
-6.55%-3.21M
78.76%-355.32K
-130.52%-3.12M
Net investment
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
-97.20%41.00
61.33%-1.36K
59.53%-1.20K
-176.65%-3.14K
-58.66%1.46K
86.91%-3.51K
Net financing
-100.06%-8.98K
61.98%3.36M
693.23%186.48K
-100.00%0.00
6878.24%14.77M
577.55%2.07M
-107.62%-31.43K
-85.70%106.03K
-72.31%211.70K
-89.50%305.74K
144318.53%412.46K
--741.23K
-92.65%764.64K
137.02%2.91M
-100.13%-286.00
-100.00%0.00
-12.91%10.40M
-38.42%1.23M
-93.15%221.04K
157.85%15.91K

FAQs

What are the current assets of Edesa Biotech Inc?

According to Edesa Biotech Inc's FY2025 earnings report, its current assets were 11.51M, with a year-on-year change of 587.08.

What are the total assets of Edesa Biotech Inc?

According to Edesa Biotech Inc's FY2025 earnings report, its total assets of Edesa Biotech Inc were 13.53M, with a year-on-year change of 254.76.

What are the total liabilities of Edesa Biotech Inc?

According to Edesa Biotech Inc's FY2025 earnings report, its total liabilities of Edesa Biotech Inc were 1.08M, with a year-on-year change of -41.15.

What is the total equity of Edesa Biotech Inc?

According to Edesa Biotech Inc's FY2025 earnings report, its total equity of Edesa Biotech Inc was 12.45M, with a year-on-year change of 528.52.

What is the net operating income of Edesa Biotech Inc?

According to Edesa Biotech Inc's FY2025 earnings report, its net operating income of Edesa Biotech Inc was -7.91M, with a year-on-year change of -12.78.

What is the net financing of Edesa Biotech Inc?

According to Edesa Biotech Inc's FY2025 earnings report, its net financing of Edesa Biotech Inc was 17.03M, with a year-on-year change of 2776.69.

What is the Earnings Per Share (EPS) of Edesa Biotech Inc?

According to Edesa Biotech Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.27, with a year-on-year change of 34.40.

What is the net income of Edesa Biotech Inc?

According to Edesa Biotech Inc's FY2025 earnings report, its net income was -7.19M, with a year-on-year change of -16.46.

What is the Return on Equity (ROE) of Edesa Biotech Inc?

According to Edesa Biotech Inc's FY2025 earnings report, its Return on Equity (ROE) was -277.81, with a year-on-year change of -103.29.

What is the Return on Assets (ROA) of Edesa Biotech Inc?

According to Edesa Biotech Inc's FY2025 earnings report, its Return on Assets (ROA) was -82.86, with a year-on-year change of 14.70.

What is the operating profit of Edesa Biotech Inc?

According to Edesa Biotech Inc's FY2025 earnings report, its operating profit was -7.91M, with a year-on-year change of -12.78.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy